Latest News about Psychedelics
Recent news which mentions Psychedelics
Is Cannabis Legalization Reducing Psychiatric Drug Use? Study Reveals Interesting Trends In Benzodiazepine, Antidepressants, Antipsychotics
September 20, 2024
Tickers
NEWS
From Benzinga
Scientists Gave LSD To Autistic Dogs: Mind-Blowing Brain Changes Deepened Connections With Humans
September 20, 2024
From Benzinga
European Initiative Pushes For Psychedelic Therapy Reform To Address $669B Mental Health Problem: The Goal Is To Gather 1 Million Signatures
September 19, 2024
From Benzinga
Alabama Marijuana Company Sues Medical Cannabis Commission Over Licensing Chaos, Seeks Program Overhaul As Patients Remain In Limbo
September 19, 2024
Tickers
NEWS
From Benzinga
Ultra-Low-Dose Ketamine May Offer Relief For Opioid Withdrawal, Study Finds
September 18, 2024
From Benzinga
Investors Back Awakn's Psychedelic Therapies, As Company Doubles Private Placement To $2M
September 18, 2024
From Benzinga
DEA Endorses New, Simplified Test To Determine Marijuana's Medical Uses Amid Rescheduling Debate: Could It Also Apply To Psychedelics?
September 17, 2024
Tickers
NEWS
From Benzinga
From Benzinga
86% Of Drug Researchers Admit To Drug Use: NYU Study
September 16, 2024
From Benzinga
Norwalk, CT's First Cannabis Dispensary Faces Solar Panel Dilemma: Tree Shade And Low ROI Hinder Compliance
September 16, 2024
Tickers
NEWS
From Benzinga
Psychedelic Biotech Psyence Grows Pipeline With Trials And Psilocybin Drug Developer Acquisition
September 16, 2024
From Benzinga
Nebraska Medical Cannabis Legalization Heads Into November Election Amid Signature Controversy
September 16, 2024
Tickers
NEWS
From Benzinga
Marijuana Sales Hit Record Highs In These 6 US States: Is Marijuana Outpacing Alcohol?
September 13, 2024
Tickers
NEWS
From Benzinga
Magic Mushrooms Boosted Humanity's Evolutionary Success, New Study Says: Did Psilocybin Make Early Humans Better Hunters?
September 13, 2024
From Benzinga
MDMA Therapy For PTSD Faces FDA Delay: Are There Other Ways Forward?
September 12, 2024
From Benzinga
LSD, MDMA And d-Amphetamine: Study Provides New Insights Into Neurobiological Effects
September 12, 2024
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.